Key Lab of Efficacy and Safety Appraisal of Chinese Materia Medica of Jiangsu Province
Key Lab of Efficacy and Safety Appraisal of Chinese Materia Medica of Jiangsu Province was established in 2008 upon the approval of the Department of Science and Technology of Jiangsu Province. Research directions: (1) establishment of the appraisal methodology and system of efficacy and safety of Chinese Materia Medica; (2) research into the normalization of efficacy and security appraisal of Chinese Materia Medica; (3) exploring new drugs with Chinese independent intellectual property rights from the traditional Chinese medicine.
-
About
-
Admission
-
Academics
-
Research
-
Distinguished Scholars
Masters of Traditional Chinese Medicine Chang Jiang Scholars The National Science Fund for Distinguished Young Scholars Selected Candidates of National Hundred, Thousand and Ten Thousand Talent Project National Distinguished Teachers Member of Disciple Appraisal Group of the Academic Degrees Committee of the State Council High-level Talents of NJUCM -
Overseas Alumni
-
Global
-
Campus Life
-
Giving
Key Lab of Efficacy and Safety Appraisal of Chinese Materia Medica of Jiangsu Province
发布时间： 2018-03-27 浏览次数： 601
Key Lab of Efficacy and Safety Appraisal of Chinese Materia Medica of Jiangsu Province was established in 2008 upon the approval of the Department of Science and Technology of Jiangsu Province. Research directions: (1) establishment of the appraisal methodology and system of efficacy and safety of Chinese Materia Medica; (2) research into the normalization of efficacy and security appraisal of Chinese Materia Medica; (3) exploring new drugs with Chinese independent intellectual property rights from the traditional Chinese medicine.
Key Lab of Efficacy and Safety Appraisal of Chinese Materia Medica of Jiangsu Province was established in 2008 upon the approval of the Department of Science and Technology of Jiangsu Province. Research directions: (1) establishment of the appraisal methodology and system of efficacy and safety of Chinese Materia Medica; (2) research into the normalization of efficacy and security appraisal of Chinese Materia Medica; (3) exploring new drugs with Chinese independent intellectual property rights from the traditional Chinese medicine.